메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kim Sun Bean (Division of Infectious Diseases Department of Internal Medicine Korea University College of Medicin) Kim Jimin (Division of Healthcare Technology Assessment Research National Evidence-based Healthcare Collaborat) Huh Kyungmin (Division of Infectious Diseases Department of Internal Medicine Samsung Medical Center Sungkyunkwan) Choi Won Suk (Division of Infectious Diseases Department of Internal Medicine Korea University College of Medicin) Kim Yae-Jean (Division of Infectious Diseases and Immunodeficiency Department of Pediatrics Samsung Medical Cente) Joo Eun-Jeong (Division of Infectious Diseases Department of Internal Medicine Sungkyunkwan University School of M) Kim Youn Jeong (Division of Infectious Diseases Department of Internal Medicine Incheon St. Mary's Hospital College) Yoon Young Kyung (Division of Infectious Diseases Department of Internal Medicine Korea University College of Medicin) Heo Jung Yeon (Department of Infectious Diseases Ajou University School of Medicine Suwon Korea.) Seo Yu Bin (Division of Infectious Diseases Department of Internal Medicine Hallym University College of Medici) Jeong Su Jin (Department of Internal Medicine Severance Hospital Yonsei University College of Medicine Seoul Kore) Yu Su-Yeon (Division of Healthcare Technology Assessment Research National Evidence-based Healthcare Collaborat) Peck Kyong Ran (Division of Infectious Diseases Department of Internal Medicine Samsung Medical Center Sungkyunkwan) Choi Miyoung (Division of Healthcare Technology Assessment Research National Evidence-based Healthcare Collaborat) Yeom Joon Sup (Department of Internal Medicine Severance Hospital Yonsei University College of Medicine Seoul Kore)
저널정보
대한감염학회 Infection and Chemotherapy Infection and Chemotherapy 제53권 제2호
발행연도
2021.1
수록면
395 - 403 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutralizing monoclonal antibodies in non-hospitalized patients with mild to moderate coronavirus disease 2019 (COVID-19) who are at high risk for progressing to severe disease and/or hospitalization. In terms of this situation, there is an urgent need to investigate the clinical aspects and to develop strategies to deploy them effectively in clinical practice. Here we provide guidance for the use of anti-SARS-CoV-2 monoclonal antibodies for the treatment of COVID-19 based on the latest evidence.

목차

등록된 정보가 없습니다.

참고문헌 (15)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0